Notes to SEFA
The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of Cure HHT under programs of the federal government for the year ended June 30, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Cure HHT, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Cure HHT.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Cure HHT has elected to use the de minimis indirect cost rate allowed under the Uniform Guidance, which was 10% prior to October 2024 and 15% effective October 2024 pursuant to changes in the Uniform Guidance.